Skip to main content
. 2023 Nov 16;14:1223746. doi: 10.3389/fphar.2023.1223746

FIGURE 3.

FIGURE 3

Acti-graph variables of dexmedetomidine (DEX) and placebo groups. The DEX group showed a significant increase in total sleep time (TST) compared to the placebo group, as well as a significant reduction in sleep onset latency (SOL) and wake after sleep onset (WASO). Dexmedetomidine treatment also significantly improved sleep efficiency (SE).